Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer - a phase II study.

By Allen M.   Vaughan M.   Webb A.   Johnston S.   Savage P.   Eisen T.   Bates S.   Morre J.   Ahern R.   Gore M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

Metastatic renal cell carcinoma treated with Peg-interferon alfa-2b

By Lyrdal David   Stierner Ulrika   Lundstam Sven  

Acta Oncologica, Vol. 48, Iss. 6, 2009-08 ,pp. : 901-908

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of interleukin 2, interferon , and 5-fluorouracil in metastatic renal cell cancer - a cytokine working group study.

By Dutcher J.   Logan T.   Gordon M.   Sosman J.   Weiss G.   Margolin K.   Plasse T.   Mier J.   Lotze M.   Clark J.   Atkins M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-84

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusional 5-Fluorouracil (5-FU) and Subcutaneous Interleukin-2 (IL-2) in Metastatic Renal Cancer

By Savage P.   Costelna D.   Moore J.   Gore M.E.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1149-1151

Elsevier

Access to resources Recommend Favorite

Different Dose Regimens of 5-Fluorouracil and Interferon- in Patients With Metastatic Colorectal Carcinoma

By Ragnhammar P.   Blomgren H.   Edler D.   Lundell G.   Magnusson I.   Sonnenfeld T.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 315-320

Elsevier

Access to resources Recommend Favorite